MiR-1236: Key controller of tumor development and progression: Focus on the biological functions and molecular mechanisms
Pathology - Research and Practice · 2023
DOI: 10.1016/j.prp.2023.154671 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2023. Verfasst von Zeinab Babaei und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry and Biophysics, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran. Hauptthemen laut MEDLINE: MicroRNAs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 89 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry and Biophysics, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
- Department of Nutrition and Biochemistry, School of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran.
- Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: maghaei@pharm.mui.ac.ir.
Zitieren
APA
Babaei, Z., Keyvanloo Shahrestanaki, M., & Aghaei, M. (2023). MiR-1236: Key controller of tumor development and progression: Focus on the biological functions and molecular mechanisms. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.154671
Vancouver
Babaei Z, Keyvanloo Shahrestanaki M, Aghaei M. MiR-1236: Key controller of tumor development and progression: Focus on the biological functions and molecular mechanisms. Pathology - Research and Practice. 2023. doi:10.1016/j.prp.2023.154671
BibTeX
@article{Babaei2023,
author = {Babaei, Zeinab and Keyvanloo Shahrestanaki, Mohammad and Aghaei, Mahmoud},
title = {MiR-1236: Key controller of tumor development and progression: Focus on the biological functions and molecular mechanisms},
journal = {Pathology - Research and Practice},
year = {2023},
doi = {10.1016/j.prp.2023.154671}
}
EUVIMED